The UK division of Japanese pharma company Takeda (TYO: 4502) has boosted its senior leadership team in a bid to drive forward its expertise in the specialty care sector.
Simon Meadowcroft (pictured above right) has joined the company as its new medical director, whilst Pauline Bromley (pictured above left) has been brought in as human resources director.
Commenting on the new appointments, Adam Zaeske, managing director, said: “Takeda is committed to advancing healthcare by developing specialist medicines that meet the needs of patients, healthcare professionals and society. The recruitment of these two new senior roles will ensure that we are perfectly positioned to deliver on our aspirations.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze